Form 4: OmniAb CEO Matthew Foehr Acquires Shares Through PSU Vesting, Sells Portion for Tax Obligations

OmniAb CEO Matthew Foehr acquired 77,003 shares through performance stock unit vesting and sold 41,811 shares to cover tax obligations.

Summary

• OmniAb CEO Matthew Foehr acquired 77,003 shares of common stock on January 17, 2025, through the vesting of performance stock units (PSUs).
• These PSUs were granted on July 5, 2022, and vested based on the company's performance through December 31, 2024.
• The Human Capital Management and Compensation Committee certified the achievement of performance objectives on January 17, 2025, approving the vesting.
• On January 21, 2025, Mr. Foehr sold 41,811 shares at a weighted average price of $3.24 per share to cover tax withholding obligations.
• The sales were mandated by the company's equity incentive plan and were not discretionary trades by Mr. Foehr.
• The sales occurred in multiple transactions with prices ranging from $3.21 to $3.27.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to executive compensation. While the sale of shares might raise minor concerns, the overall sentiment is neutral to slightly positive due to the vesting of PSUs based on performance.

Positives

• The vesting of performance stock units indicates that the company met its performance objectives.
• The CEO's acquisition of shares through vesting aligns his interests with the company's performance.

Negatives

• The sale of shares, even for tax purposes, could be perceived negatively by some investors.

Risks

• The sale of a significant number of shares by the CEO, even for tax obligations, could potentially create short-term selling pressure on the stock.
• The market may interpret the sale as a lack of confidence in the company's future performance, despite the explanation provided.

Management Comments

• The sales were mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell-to-cover' transaction and do not represent discretionary trades by the reporting person.

Industry Context

This type of transaction is common for executives who receive equity compensation, and the sale of shares to cover tax obligations is a standard practice.

Comparison to Industry Standards

• Many biotech and pharmaceutical companies use performance-based equity awards to incentivize their executives.
• Sell-to-cover transactions are a common mechanism for executives to manage tax liabilities associated with equity vesting.
• The vesting of PSUs based on performance metrics is a standard practice in the industry to align executive compensation with company goals.
• Comparable companies such as Regeneron, Amgen, and Gilead also use similar equity compensation structures.

Stakeholder Impact

• Shareholders may have a neutral to slightly negative reaction to the sale of shares, even if it is for tax purposes.
• Employees may view the vesting of PSUs as a positive sign of the company's performance.

Key Dates

Keywords

OmniAb, Matthew Foehr, performance stock units, PSU, vesting, stock sale, tax obligations, insider trading, equity incentive plan